Trial Profile
Long-term effects of insulin plus metformin regimens on the overall and postprandial glycemic control of patients with type 2 diabetes: a comparison of premeal insulin lispro mixtures to once-daily insulin glargine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Sponsors Eli Lilly and Company
- 25 Apr 2011 Results published in Diabetic Medicine.
- 13 Nov 2005 New trial record.